RxDoctor Payments Data

Dylan Taylor

Physician Assistant · East Carbon, UTNPI 1699146233

Payments from drug & device makers

$1,307in general payments, 2019–2025

Across 78 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$790
  • Gilead$76
  • AstraZeneca$64
  • Pfizer$56
  • Collegium Pharmaceutical, Inc.$49
  • Alkermes, Inc.$49
  • plus $223 from 10 others

What the payments were for

  • Food & beverage$1,307100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,307 in reported general payments places this provider in the 75th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Medicare billing

Part B allowed, 2024
$329
Medicare patients
25
Services billed
31

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin43$38,151
JanuviaSitagliptin Phosphate32$27,688
TrulicityDulaglutide28$25,871
FarxigaDapagliflozin Propanediol16$14,634
XareltoRivaroxaban14$9,684
EntrestoSacubitril/Valsartan13$8,540
LyricaPregabalin12$6,521
SymbicortBudesonide/Formoterol Fumarate14$4,739
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$4,166
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$1,475
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl16$1,166
Albuterol Sulfate HfaAlbuterol Sulfate43$1,129
Omeprazole68$926
Levothyroxine Sodium111$912
Gabapentin60$869

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$34$38,15143 claims
AstraZenecaFarxiga, Symbicort$64$19,37330 claims
PfizerLyrica$56$6,52112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in East Carbon

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →